Posted by Michael Wonder on 24 Feb 2021
Anti-cancer drugs Ninlaro, Lutathera to get insurance benefits from March
24 February 2021 - Takeda’s multiple myeloma treatment Ninlaro (ixazomib) and Novartis’ neuroendocrine tumour drug Lutathera (lutetium oxodotreotide) will get health insurance benefits from March 1.
Novartis’ macular degeneration drug Beovu (brolucizumab) will also be covered by insurance from April 1.
